How TPG’s decade-long thematic focus lent to the creation Ellodi, a new specialty pharma business

Ellodi's clinical assets were spun out of TPG's Adare, which grew EBITDA at a CAGR north of 25 percent under the PE firm's hold, a source told PE Hub.